Pacira BioSciences (PCRX)
(Delayed Data from NSDQ)
$14.19 USD
+0.22 (1.57%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $14.18 -0.01 (-0.07%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth C Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/7/24 |
---|---|
Current Quarter | 0.74 |
EPS Last Quarter | 0.89 |
Last EPS Surprise | 21.92% |
ABR | 2.89 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 3.07 |
Next Year | 2.95 |
EPS (TTM) | 3.12 |
P/E (F1) | 4.62 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 170.00M | 177.17M | 691.63M | 639.34M |
# of Estimates | 7 | 7 | 7 | 7 |
High Estimate | 173.92M | 186.50M | 701.60M | 777.78M |
Low Estimate | 167.28M | 164.00M | 675.34M | 435.30M |
Year ago Sales | 163.93M | 181.24M | 674.98M | 691.63M |
Year over Year Growth Est. | 3.70% | -2.24% | 2.47% | -7.56% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.74 | 0.85 | 3.07 | 2.95 |
# of Estimates | 7 | 7 | 7 | 7 |
Most Recent Consensus | 0.65 | 0.80 | 2.96 | 3.67 |
High Estimate | 1.06 | 1.04 | 3.58 | 3.85 |
Low Estimate | 0.65 | 0.75 | 2.83 | 1.01 |
Year ago EPS | 0.72 | 0.89 | 2.81 | 3.07 |
Year over Year Growth Est. | 2.78% | -4.49% | 9.25% | -4.00% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 1 | 1 |
Up Last 30 Days | 4 | 3 | 5 | 2 |
Up Last 60 Days | 4 | 3 | 5 | 2 |
Down Last 7 Days | 1 | 1 | 0 | 0 |
Down Last 30 Days | 3 | 3 | 2 | 5 |
Down Last 60 Days | 3 | 3 | 2 | 5 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.74 | 0.85 | 3.07 | 2.95 |
7 Days Ago | 0.74 | 0.86 | 3.06 | 2.93 |
30 Days Ago | 0.71 | 0.88 | 2.93 | 3.76 |
60 Days Ago | 0.72 | 0.88 | 2.94 | 3.75 |
90 Days Ago | 0.67 | 0.80 | 2.71 | 3.43 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.74 | 0.86 | 3.07 | 2.95 |
Zacks Consensus Estimate | 0.74 | 0.85 | 3.07 | 2.95 |
Earnings ESP | 0.00% | 1.06% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.89 | 0.62 | 0.89 | 0.72 | NA |
Estimate | 0.73 | 0.64 | 0.89 | 0.84 | NA |
Difference | 0.16 | -0.02 | 0.00 | -0.12 | 0.01 |
Surprise | 21.92% | -3.12% | 0.00% | -14.29% | 1.13% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more